Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 2
2001 2
2002 2
2003 1
2004 1
2007 1
2009 1
2010 1
2018 1
2019 1
2020 1
2021 6
2022 9
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.
Passaro A, Wang J, Wang Y, Lee SH, Melosky B, Shih JY, Wang J, Azuma K, Juan-Vidal O, Cobo M, Felip E, Girard N, Cortot AB, Califano R, Cappuzzo F, Owen S, Popat S, Tan JL, Salinas J, Tomasini P, Gentzler RD, William WN Jr, Reckamp KL, Takahashi T, Ganguly S, Kowalski DM, Bearz A, MacKean M, Barala P, Bourla AB, Girvin A, Greger J, Millington D, Withelder M, Xie J, Sun T, Shah S, Diorio B, Knoblauch RE, Bauml JM, Campelo RG, Cho BC; MARIPOSA-2 Investigators. Passaro A, et al. Among authors: girvin a. Ann Oncol. 2024 Jan;35(1):77-90. doi: 10.1016/j.annonc.2023.10.117. Epub 2023 Oct 23. Ann Oncol. 2024. PMID: 37879444 Free article. Clinical Trial.
Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program.
Brannock MD, Chew RF, Preiss AJ, Hadley EC, Redfield S, McMurry JA, Leese PJ, Girvin AT, Crosskey M, Zhou AG, Moffitt RA, Funk MJ, Pfaff ER, Haendel MA, Chute CG; N3C; RECOVER Consortia. Brannock MD, et al. Among authors: girvin at. Nat Commun. 2023 May 22;14(1):2914. doi: 10.1038/s41467-023-38388-7. Nat Commun. 2023. PMID: 37217471 Free PMC article.
Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma.
Peat TJ, Gaikwad SM, Dubois W, Gyabaah-Kessie N, Zhang S, Gorjifard S, Phyo Z, Andres M, Hughitt VK, Simpson RM, Miller MA, Girvin AT, Taylor A, Williams D, D'Antonio N, Zhang Y, Rajagopalan A, Flietner E, Wilson K, Zhang X, Shinn P, Klumpp-Thomas C, McKnight C, Itkin Z, Chen L, Kazandijian D, Zhang J, Michalowski AM, Simmons JK, Keats J, Thomas CJ, Mock BA. Peat TJ, et al. Among authors: girvin at. Cancer Lett. 2023 Aug 1;568:216284. doi: 10.1016/j.canlet.2023.216284. Epub 2023 Jun 24. Cancer Lett. 2023. PMID: 37356470 Free PMC article.
Coding long COVID: characterizing a new disease through an ICD-10 lens.
Pfaff ER, Madlock-Brown C, Baratta JM, Bhatia A, Davis H, Girvin A, Hill E, Kelly E, Kostka K, Loomba J, McMurry JA, Wong R, Bennett TD, Moffitt R, Chute CG, Haendel M; N3C Consortium; RECOVER Consortium. Pfaff ER, et al. Among authors: girvin a. BMC Med. 2023 Feb 16;21(1):58. doi: 10.1186/s12916-023-02737-6. BMC Med. 2023. PMID: 36793086 Free PMC article.
Coding Long COVID: Characterizing a new disease through an ICD-10 lens.
Pfaff ER, Madlock-Brown C, Baratta JM, Bhatia A, Davis H, Girvin A, Hill E, Kelly L, Kostka K, Loomba J, McMurry JA, Wong R, Bennett TD, Moffitt R, Chute CG, Haendel M; N3C Consortium; RECOVER Consortium. Pfaff ER, et al. Among authors: girvin a. medRxiv [Preprint]. 2022 Sep 2:2022.04.18.22273968. doi: 10.1101/2022.04.18.22273968. medRxiv. 2022. Update in: BMC Med. 2023 Feb 16;21(1):58. doi: 10.1186/s12916-023-02737-6. PMID: 36093345 Free PMC article. Updated. Preprint.
Referrals to dermatology following solid organ transplant.
Shope C, Andrews L, Girvin A, Linkous C, Lee LW. Shope C, et al. Among authors: girvin a. J Am Acad Dermatol. 2023 May;88(5):1159-1160. doi: 10.1016/j.jaad.2022.11.052. Epub 2022 Dec 5. J Am Acad Dermatol. 2023. PMID: 36470310 No abstract available.
Cancer genes disfavoring T cell immunity identified via integrated systems approach.
Kishton RJ, Patel SJ, Decker AE, Vodnala SK, Cam M, Yamamoto TN, Patel Y, Sukumar M, Yu Z, Ji M, Henning AN, Gurusamy D, Palmer DC, Stefanescu RA, Girvin AT, Lo W, Pasetto A, Malekzadeh P, Deniger DC, Wood KC, Sanjana NE, Restifo NP. Kishton RJ, et al. Among authors: girvin at. Cell Rep. 2022 Aug 2;40(5):111153. doi: 10.1016/j.celrep.2022.111153. Cell Rep. 2022. PMID: 35926468 Free PMC article.
Identifying who has long COVID in the USA: a machine learning approach using N3C data.
Pfaff ER, Girvin AT, Bennett TD, Bhatia A, Brooks IM, Deer RR, Dekermanjian JP, Jolley SE, Kahn MG, Kostka K, McMurry JA, Moffitt R, Walden A, Chute CG, Haendel MA; N3C Consortium. Pfaff ER, et al. Among authors: girvin at. Lancet Digit Health. 2022 Jul;4(7):e532-e541. doi: 10.1016/S2589-7500(22)00048-6. Epub 2022 May 16. Lancet Digit Health. 2022. PMID: 35589549 Free PMC article.
Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER Program.
Brannock MD, Chew RF, Preiss AJ, Hadley EC, McMurry JA, Leese PJ, Girvin AT, Crosskey M, Zhou AG, Moffitt RA, Funk MJ, Pfaff ER, Haendel MA, Chute CG; N3C and RECOVER Consortia. Brannock MD, et al. Among authors: girvin at. medRxiv [Preprint]. 2022 Oct 7:2022.10.06.22280795. doi: 10.1101/2022.10.06.22280795. medRxiv. 2022. Update in: Nat Commun. 2023 May 22;14(1):2914. doi: 10.1038/s41467-023-38388-7. PMID: 36238713 Free PMC article. Updated. Preprint.
41 results